… Our findings are consistent with a meta-analysis of the effect of β-blocker therapy in heart
failure, which found that the addition of β-blocker therapy to conventional treatment was …

… have analyzed β-blockers in heart failure of all etiologies (… in the modern arena of heart failure,
seeking benefit in the … of β-blockers, β-blocker therapy was added to standard therapy that …

… treated with metoprolol [ 14 ], we hypothesized that this synergy may also influence the
response to β-blocker therapy. Given the elevated norepinephrine release with the ADRA2C Del …

… Beta-blocker therapy was associated with a decreased hazard risk (HR) of all-cause death
[… commencement of beta-blocker therapy with the prognosis of heart failure patients with new-…

… long-term β-blocker therapy for ≥1 year and β-blocker therapy for <1 year after AMI, we
excluded patients who had not been prescribed any β-blockers within 3 months after hospital …

… -blocker therapy with either metoprolol or carvedilol in addition to conventional therapy for
patients with heart failure … expectancy for treating patients with conventional therapy alone and …

… and with non selective beta-blockers for mortality.These results suggest that beta-blocker
therapy may induce functional and survival improvement in heart failure, but results on …

… However, none of the aforementioned defects would seem to change the positive trend
toward better fractal control of HRV during betablocker therapy of advanced heart failure, as …

… of 551 patients with systolic dysfunction referred to a heart failure clinic in an … patients with
a follow-up echocardiogram stratified by response to β-blocker therapy initiated in heart failure …

… benefit patients with HFpEF [5]. Beta-blockers are the mainstay of treatment in heart failure
with … In randomized control trials of HFrEF, beta-blockers led to significant improvement in all-…